Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

34 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The existing records of a private practice limited to the practice of periodontology were reviewed to locate patients who had been diagnosed with peri-implantitis (failing dental implant) and had been surgically treated utilizing enamel matrix derivative (Commercially available FDA product Emdogain sold by Straumann USA). Various clinical factors were gathered from the existing records. Some of the factors recorded were: retention of the implant, presence of bleeding, presence of further damage, and presence of inflammation. All patients had signed an informed consent for treatment and the anonymous use of their data for research purposes. All HIPA requirements were followed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Immediately Placed Dental Implants With Local Application of Injectable PRF in Periodontally Compromised Sites

NCT04029779

Bone Density Bone Loss, Alveolar

COMPLETED PHASE2

Clinical Outcomes of Immediate Implants With or Without a Volume-stable Collagen Matrix

NCT05081284

Edentulous Alveolar Ridge

RECRUITING NA

Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis

NCT03400475

Peri-implant Mucositis

COMPLETED PHASE2

Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty

NCT04259840

Peri-Implantitis

TERMINATED

Emdogain Adjunctive to Autotransplantation

NCT06250088

Autotransplantation Emdogain Autologous Transplantation +1 more

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

See brief summary.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Determination of Beneficial Effect of Using Enamel Matrix Derivative During Implant Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

peri-implantitis surgery with enamel matrix derivative

surgical procedures around dental implants with peri-implantits to remove infectious material and apply enamel matrix derivative to the implant.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all adult patients of record who presented with existing peri-implantitis that was clinically deemed treatable (the implant was not considered hopeless.)